AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal Augmentation

RecruitingNAAges 18 Years - anyFemaleEstablishment Labs
💬

In plain words

What the trial is, and whether it could suit you

The objective of this clinical trial is to assess the initial performance and safety of Motiva® Ergonomix2® Diamond®, Motiva Injector®, Motiva® Inflatable Balloon, Motiva® Reusable Channel Dissector, and Motiva® GEM Channel Separator utilized in a minimally invasive gluteal augmentation procedure, involving 120 healthy female participants. The main questions it aims to answer are: * Are the main side effects and complications experienced by participants who underwent a minimally invasive buttock enhancement procedure with Motiva Ergonomix2® Diamond®, the Motiva Injector®, the Motiva® Inflatable Balloon, the Motiva® Reusable Channel Dissector, and Motiva® GEM Channel Separator adequately characterized? * Can the Motiva Injector®, Motiva® Inflatable Balloon, the Motiva® Reusable Channel Dissector, and Motiva® GEM Channel Separator be successfully utilized, and are any failures in the pro

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Cisgender women, aged 18 years or older. * Participants without prior buttock augmentation or biopolymer injections in the buttocks. * Participants classified as ASA class I and II according to the American Society of Anesthesiologists (ASA) classification system for estimating risk. * Participants seeking buttock enhancement, aiming to simply restore the aesthetic curvature of the back. * Body mass index between 18.5 and 28. * Adequate tissue available to cover the implant(s). * Willingness to comply with all study requirements and agree to attend all required follow-up visits. * Agreement to return the device to the sponsor in case of explantation. Exclusion Criteria: * Women with massive weight loss. * Buttock ptosis or poor skin quality. * Inadequate tissue (e.g., due to radiation damage, ulceration, compromised vascularization, history of compromised healing). * Current pregnancy. * History of abscesses or infections in the buttock area. * History of sensitivity to silicone. * Any medical condition such as underweight or obesity according to inclusion criteria, diabetes, autoimmune disease, or severe chronic pulmonary or cardiovascular disease resulting in excessively high surgical risk and significant postoperative complications. * History of psychological characteristics that are unrealistic or unreasonable given the risks associated with the surgical procedure. * Use of any medication that, according to the investigator's experience, may pose a higher risk of complications or interfere with wound healing capacity, such as corticosteroid treatment or blood-thinning medications (e.g., concomitant treatment with warfarin). * Participants who do not reside in the Great Metropolitan Area of Costa Rica, which makes it difficult for them to attend follow-up visits.
💊

What it tests

  • Primary gluteal enhancement
📍

Where

1 site
Establishment Labs
Alajuela, Costa Rica
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy